Literature DB >> 12484088

[Endoscopic local injection of anticancer drugs bound to carbon particles for treatment of advanced rectal cancer, when surgical treatment was contraindicated].

Shuichi Kin1, Yuen Nakase, Kenichirou Fukuda, Tadao Ito, Katsumi Shimomura, Tsuyoshi Takagi, Atsushi Toma, Junshin Fujiyama, Kazuma Okamoto, Chouhei Sakakura, Eigo Otsuji, Kazuya Kitamura, Hirosumi Itoi, Akeo Hagiwara, Hisakazu Yamagishi.   

Abstract

Generally, patients with advanced rectal cancer in whom surgical treatment is contraindicated receive radiation or chemotherapy. In such patients, we have administered local injection of methotrexate and mitomycin C bound to activated carbon particles. Four patients received intratumoral injection of the dosage formulation (total dose 100-400 mg of methotrexate or 8-32 mg of mitomycin C) under colonofiberscope. After the treatment, bleeding and pain were lessened in all 4 patients. In two patients, the tumor markedly decreased in size and there was no regrowth prior to death 12-14 months after the treatment. In another patient, bleeding and pain disappeared until the patient died of pulmonary and liver metastases. The fourth patient is alive without regrowth 5 months after treatment. Side effects were not severe.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484088

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  2 in total

1.  Hybrid anisotropic nanostructures for dual-modal cancer imaging and image-guided chemo-thermo therapies.

Authors:  Ruiping Zhang; Kai Cheng; Alexander L Antaris; Xiaowei Ma; Min Yang; Sindhuja Ramakrishnan; Guifeng Liu; Alex Lu; Hongjie Dai; Mei Tian; Zhen Cheng
Journal:  Biomaterials       Date:  2016-07-02       Impact factor: 12.479

2.  Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer.

Authors:  Jianghao Chen; Ling Wang; Qing Yao; Rui Ling; Kaizong Li; Hui Wang
Journal:  Breast Cancer Res       Date:  2004-06-17       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.